Skip to main content
. Author manuscript; available in PMC: 2018 Apr 9.
Published in final edited form as: Bone Marrow Transplant. 2017 Oct 9;52(12):1629–1636. doi: 10.1038/bmt.2017.197

Table 3. Results of univariate and multivariate Cox regression analyses for association of patient and transplant factors with relapse-free and overall survival.

Characteristic Univariate Multivariate
RFS OS RFS OS
HR (95% CI) p HR (95% CI) p HR (95% CI) p HR (95% CI) p
Age, per 10 year 1.24 (1.01, 1.51) 0.04 1.30 (1.04, 1.62) 0.02 1.16 (0.89, 1.50) 0.27 1.17 (0.92, 1.48) 0.19
HCT-CI 0 1.0 (reference) 0.02 1.0 (reference 0.003 1.0 (reference) 0.02 1.0 (reference) 0.004
1–2 0.85 (0.43,1.67) 1.06 (0.48,2.34) 0.83 (0.42,1.65) 1.05 (0.47, 2.33)
≥ 3 1.77 (0.99,3.16) 2.51 (1.28,4.9) 1.78 (0.97,3.28) 2.53 (1.26, 5.08)
KPS 60–80 1.0 (reference) 0.42 1.0 (reference) 0.09
90–100 0.82 (0.52, 1.32) 0.65 (0.39, 1.07)
Donor type MRD 1.0 (reference) 0.10 1.0 (reference) 0.06
MUD 1.03 (0.57,1.85) 0.91 (0.47,1.74)
MMRD 2.32 (0.8,6.69) 2.6 (0.89,7.57)
MMUD 1.75 (1,3.06) 1.76 (0.97,3.19)
Conditioning regimen TBI-based 1.0 (reference) 0.04 1.0 (reference) 0.07 1.0 (reference) 0.90
Chemo-based 1.67 (1.01, 2.76) 1.65 (0.96, 2.83) 1.04 (0.55, 1.97)
CD34 selectionmethod ISOLEX 1.0 (reference) 0.88 1.0 (reference) 0.61
CliniMACS 1.04 (0.63, 1.71) 0.87 (0.50, 1.51)
Acute GVHD by 1 year No 1.0 (reference) 0.002 1.0 (reference) 0.001
Yes 2.17 (1.34,3.50) 2.32 (1.39,3.88)
Acute GVHD grade by 1 year 0–1 1.0 (reference) <0.0001 1.0 (reference) <0.0001 1.0 (reference) <0.0001 1.0 (reference) <0.0001
2 1.97 (0.97,4.02) 2.62 (1.27, 5.39) 2.07 (1.01, 4.27) 2.90 (1.39, 6.04)
3–4 5.43 (2.82,10.46) 5.61 (2.81, 11.22) 6.14 (3.12, 12.07) 6.14 (3.05, 12.36)
Chronic GVHD by 1 year No 1.0 (reference) 0.62 1.0 (reference) 0.336
Yes 1.24 (0.54,2.85) 1.51 (0.65,3.51)